Phase II Study of the Early Use of Docetaxel in Patients With Biochemical Relapse After Primary Therapy for Prostate Cancer and an Incomplete Response to Androgen Deprivation Therapy.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Docetaxel (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 28 Apr 2017 Biomarkers information updated
- 27 Jul 2010 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 15 Sep 2009 Actual end date (Jul 2009) added as reported by ClinicalTrials.gov.